Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| MCRA | INDUSTRY |
Not provided
Not provided
This is a multi-site, observational clinical study to validate the performance of the CLAiR AI software in identifying elevated atherosclerotic cardiovascular disease (ASCVD) risk from retinal (eye) images obtained from two different retinal image camera models.
This is a prospective observational clinical study to collect retinal images and clinical biomarker data in order to analyze the performance of the CLAiR SaMD compared to the reference PCE risk score. CLAiR is a deep learning (DL) model that uses retinal photographs and limited demographic data to classify an individual's risk of developing ASCVD over the next 10 years as elevated (≥7.5%) or non-elevated (<7.5%). For validation, the output of the algorithm can be directly compared to the PCE output, a widely accepted algorithm used by Healthcare Providers to predict ASCVD risk in patients.
The primary hypothesis is that the CLAiR SaMD can achieve high sensitivity and specificity in the binary determination of Yes/No elevated ASCVD risk with PCE risk score ≥7.5% as the reference standard.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CLAIR | Other | Subject will have retinal images obtained and uploaded to CLAiR Software. Subjects are not directly in contact with CLAiR software. There is no medical intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| Demonstrate that CLAiR can accurately identify elevated ASCVD risk as determined by PCE score. | Sensitivity and Specificity of CLAiR binary elevated risk classification (PCE ≥ 7.5% Y/N) against the reference standard of PCE ≥ 7.5% | through study completion, an average of 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
Known history of atherosclerotic cardiovascular disease, including stroke, heart attack, coronary artery surgery, or stenting
Current use of cholesterol-lowering medication, such as a statin
Pregnancy
A person who has (in at least one eye):
Not provided
Not provided
Males and Females between the ages of 40-75 years of age.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yariv Levinson | Contact | (240) 442 2479 | yariv.levin@tokueyes.com |
| Name | Affiliation | Role |
|---|---|---|
| Michael McConnell, MD | Toku Inc. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Diabetes and Endocrine Associates of Stark County | Recruiting | Canton | Ohio | 44718 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided